Produced by: Manoj Kumar
Ozempic’s growing popularity lies in its dual ability to manage diabetes and promote weight loss, raising questions about its off-label use among celebrities and the elite in India.
Ozempic stimulates insulin secretion and suppresses glucagon, helping control blood glucose levels effectively, especially post-meal, according to clinical studies.
By targeting the brain's appetite centers, Ozempic suppresses hunger, promoting significant calorie reduction and aiding weight loss over time.
The drug delays gastric emptying, moderating the rate at which glucose enters the bloodstream, which stabilizes sugar levels and curbs cravings.
With a half-life of seven days due to structural modifications, Ozempic allows for convenient once-weekly dosing, making it appealing for users managing diabetes or seeking weight loss.
While officially unavailable in India, wealthy individuals reportedly acquire Ozempic through gray market channels, importing it from Europe or carrying it in personal luggage.
Speculation surrounds high-profile figures like filmmaker Karan Johar regarding Ozempic’s use for weight loss, though Johar has denied the claims.
Studies reveal patients lose 6.4 kg over 40 weeks or about 15% of body weight over 68 weeks using Ozempic, with results visible within weeks of treatment.
Common side effects include nausea and constipation, while rare risks involve pancreatitis and kidney issues. Monitoring by healthcare professionals is crucial during use, notes Dr. Jagadish Hiremath.